Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-039021
Filing Date
2025-03-13
Accepted
2025-03-13 19:31:01
Documents
1
Period of Report
2025-03-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6030
  Complete submission text file 0000950170-25-039021.txt   7427
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 - 3650 GILMORE WAY BURNABY, A1 V5G 48W
Business Address
KENNEY CHRISTOPHER JOHN (Reporting) CIK: 0001880129 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 25737300